TUMOR, SOLID
Clinical trials for TUMOR, SOLID explained in plain language.
Never miss a new study
Get alerted when new TUMOR, SOLID trials appear
Sign up with your email to follow new studies for TUMOR, SOLID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves zap kidney tumors in first human trial
Disease control CompletedThis study tested a new device that uses focused ultrasound (histotripsy) to break apart solid kidney tumors without making any cuts. Twenty adults with small, non-spreading kidney tumors were treated. The main goals were to see if the device could fully cover the tumor and if th…
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New combo therapy shows promise in early cancer trial
Disease control CompletedThis early-stage study tested an experimental drug called BDB001, alone or with another drug (atezolizumab), in 40 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. Researchers a…
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New combo therapy for advanced tumors shows early promise
Disease control CompletedThis early-stage trial tested a new drug called BDB001, alone or with another drug (pembrolizumab), in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the best dose. Only one person took part, so res…
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:09 UTC
-
Immunotherapy duo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (durvalumab and tremelimumab) could help people with recurrent solid tumors that have a high number of genetic mutations. The trial enrolled 14 adults whose cancer had returned or not responded to prior treatments…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New proton therapy machine shows promise in tumor control
Disease control CompletedThis study tested a new proton therapy machine (Varian ProBeam360°) in 47 people with solid tumors. The goal was to see if it could control tumor growth and keep side effects low. Results were compared to a set standard to help get the device approved for use.
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New antibody combo tested for tough cancers
Disease control CompletedThis early-phase study tested a new experimental drug called HMBD-002, alone or with another cancer drug (pembrolizumab), in 48 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see …
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for patients whose tumors resist immunotherapy?
Disease control CompletedThis study tested an experimental drug called BDB001 in people with advanced solid tumors that had stopped responding to standard immunotherapy (PD-1 or PD-L1 blockers). The goal was to see if BDB001 could shrink tumors or slow their growth. Only one person was enrolled, so resul…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo therapy tested for tough cancers
Disease control CompletedThis early-phase study tested an experimental drug called BDB001, given alone or with pembrolizumab, in 87 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the best dose. This is not a cure; it aims…
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Proton beam zaps tumors: 47-Patient trial shows promise
Disease control CompletedThis study tested a new proton therapy machine (Varian ProBeam) in 47 people with solid tumors. The goal was to see if the machine safely controls tumors 90 days after treatment. Researchers measured tumor response and side effects to support approval of the device.
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated May 12, 2026 13:41 UTC